← Open Payments lookup

NICHOLAS SANTALUCIA: Open Payments

NPI 1255065488 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,645 in 55 payments from 11 companies in 2025. Trend: 2023 $1,045 · 2024 $1,132 · 2025 $1,645

Food & beverage: $1,645
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$335
Neurocrine BioSciences, Inc.15$327
Vanda Pharmaceuticals Inc.6$305
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$220
E.R. Squibb & Sons, L.L.C.4$180
Teva Pharmaceuticals USA, Inc.6$101
ABBVIE INC.3$58
Janssen Pharmaceuticals, Inc1$42
Takeda Pharmaceuticals U.S.A., Inc.2$32
Lundbeck LLC1$25

Products named: INGREZZA, REXULTI, FANAPT, CAPLYTA, COBENFY, AUSTEDO XR, VRAYLAR, ABILIFY MAINTENA.

Industry payments across VA — which companies pay providers there.